The report will be delivered in 2-3 business days.

Alzheimer’s Disease Treatment Global Market Report 2021 - By Drug Class (Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins), By Drug Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists), By Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics), COVID-19 Growth And Change

aboutimg
Purchase Options
Request Sample
Request For Discount
FAQ
Infoimg

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7719 | Format :


Description Table Of Contents Tables & Figures Market Insights Related Reports

The global Alzheimer’s disease treatment market consists of sales of drugs used to treat Alzheimer’s disease. Alzheimer's disease is a progressive neurological disorder causing degeneration of brain cells, resulting in dementia (a condition that causes a decline in thinking, behavioural and social skills). The progression of this disease causes severe memory impairment and the person may lose the ability to carry out everyday tasks.

The Alzheimer’s disease treatment market covered in this report is segmented by drug class into cholinergic, memantine, combined drug, AChE inhibitors, immunoglobulins and by drug type into cholinesterase inhibitors, NMDA receptor antagonists.

The global Alzheimer’s disease treatment market is expected to grow from $3.43 billion in 2020 to $3.76 billion in 2021 at a compound annual growth rate (CAGR) of 9.6%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The global Alzheimer’s disease treatment market is expected to reach $5.91 billion in 2025 at a CAGR of 12%.

The increasing cases of Alzheimer's is a major factor contributing to the growth of the Alzheimer's treatment market. Alzheimer's is the most common type of dementia. The USA Alzheimer's Association expects that all the states in the US are projected to face a rise of at least 14% in the number of Alzheimer’s people between 2017 and 2025 due to the increase in the geriatric population. At the global level, the estimated new cases of Alzheimer’s is expected to grow by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Therefore, the increasing prevalence of Alzheimer’s disease is expected to drive the growth of the global Alzheimer’s disease treatment market.

 

Lack of techniques for diagnosing Alzheimer’s disease (AD) is expected to limit the growth of the global Alzheimer’s disease treatment market. There is no definitive blood test, brain scan, or physical exam to diagnose AD, and so many conditions can produce symptoms like dementia, which is the primary clinical symptom of AD, making the diagnosis complicated. The lack of a single test for diagnosis, specialists such as neurologists, neuropsychologists, geriatricians and geriatric psychiatrists use a variety of approaches for diagnosis to confirm dementia, but it is still difficult to find the cause resulting in late diagnosis. Lack of proper and quick diagnosis for AD hampers the market growth as it leads to a reduced number of diagnosed cases and thereby reduces the consumption of AD drugs.

 

Increasing R&D investments and collaborations due to the emerging technologies for the treatment is a key trend in Alzheimer’s disease (AD) treatment market. The Alzheimer's Association is assisting with funds to researchers in search of innovative therapeutic approaches and seeks more government funding for Alzheimer's studies. Technologies such as ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and anti-amyloid inhibitors are emerging in the AD market. For instance, Comentis and Astellas collaborated and entered the BACE inhibitor field on their peptidomimetic series. Manufacturing companies such as AC Immune, Adamas Pharmaceuticals, INmune Bio, Intra-Cellular Therapies, vTv Therapeutics are more focused on R&D investments with their research molecules in the clinical trials to achieve a breakthrough for the treatment of AD.

 

In January 2020, Biogen Inc., an American multinational biotechnology company, acquired Pfizer Inc. for an upfront payment of $75 million with up to $635 million in potential additional development and commercialization milestone payments. Through this acquisition, Biogen plans to develop the Phase 1 asset for the treatment of Sundowning in Alzheimer’s disease (AD) and Irregular Sleep Wake Rhythm Disorder (ISWRD) in Parkinson’s disease (PD). Pfizer Inc. is an American multinational pharmaceutical corporation engaged in the discovery, development and manufacture of healthcare products including medicines and vaccines.

 

Major players in the global Alzheimer’s disease treatment market are Allergan, Eisai Co. Ltd., Novartis AG, Pfizer Inc., Merz Pharma, H. Lundbeck A/S Biogen, AstraZeneca, and F. Hoffmann-La Roche Ltd.

The regions covered in the global Alzheimer’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the global Alzheimer’s disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global Alzheimer’s disease treatment market is segmented -

1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins

2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists

3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

    Table Of Contents

    1. Executive Summary

    2. Alzheimer’s Disease Treatment Market Characteristics

    3. Alzheimer’s Disease Treatment Market Trends And Strategies

    4. Impact Of COVID-19 On Alzheimer’s Disease Treatment

    5. Alzheimer’s Disease Treatment Market Size And Growth

    5.1. Global Alzheimer’s Disease Treatment Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Alzheimer’s Disease Treatment Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Alzheimer’s Disease Treatment Market Segmentation

    6.1. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cholinergic

    Memantine

    Combined Drug

    AChE inhibitors

    Immunoglobulins

    6.2. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cholinesterase Inhibitors

    NMDA Receptor Antagonists

    6.3. Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cholinesterase Inhibitors

    NMDA Receptor Antagonists

    Other Therapeutics

    7. Alzheimer’s Disease Treatment Market Regional And Country Analysis

    7.1. Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Alzheimer’s Disease Treatment Market

    8.1. Asia-Pacific Alzheimer’s Disease Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Alzheimer’s Disease Treatment Market

    9.1. China Alzheimer’s Disease Treatment Market Overview

    9.2. China Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Alzheimer’s Disease Treatment Market

    10.1. India Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Alzheimer’s Disease Treatment Market

    11.1. Japan Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Alzheimer’s Disease Treatment Market

    12.1. Australia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Alzheimer’s Disease Treatment Market

    13.1. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Alzheimer’s Disease Treatment Market

    14.1. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Alzheimer’s Disease Treatment Market

    15.1. Western Europe Alzheimer’s Disease Treatment Market Overview

    15.2. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Alzheimer’s Disease Treatment Market

    16.1. UK Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Alzheimer’s Disease Treatment Market

    17.1. Germany Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Alzheimer’s Disease Treatment Market

    18.3. France Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Alzheimer’s Disease Treatment Market

    19.1. Eastern Europe Alzheimer’s Disease Treatment Market Overview

    19.2. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Alzheimer’s Disease Treatment Market

    20.1. Russia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Alzheimer’s Disease Treatment Market

    21.1. North America Alzheimer’s Disease Treatment Market Overview

    21.2. North America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Alzheimer’s Disease Treatment Market

    22.1. USA Alzheimer’s Disease Treatment Market Overview

    22.2. USA Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Alzheimer’s Disease Treatment Market

    23.1. South America Alzheimer’s Disease Treatment Market Overview

    23.2. South America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Alzheimer’s Disease Treatment Market

    24.1. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Alzheimer’s Disease Treatment Market

    25.1. Middle East Alzheimer’s Disease Treatment Market Overview

    25.2. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Alzheimer’s Disease Treatment Market

    26.1. Africa Alzheimer’s Disease Treatment Market Overview

    26.2. Africa Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Alzheimer’s Disease Treatment Market Competitive Landscape And Company Profiles

    27.1. Alzheimer’s Disease Treatment Market Competitive Landscape

    27.2. Alzheimer’s Disease Treatment Market Company Profiles

    27.2.1. Allergan

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Eisai Co. Ltd.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Novartis AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Pfizer Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Merz Pharma

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Alzheimer’s Disease Treatment Pipeline Analysis

    29. Key Mergers And Acquisitions In The Alzheimer’s Disease Treatment Market

    30. Alzheimer’s Disease Treatment Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Allergan Financial Performance
  • Table 28: Eisai Co. Ltd. Financial Performance
  • Table 29: Novartis AG Financial Performance
  • Table 30: Pfizer Inc. Financial Performance
  • Table 31: Merz Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Allergan Financial Performance
  • Figure 28: Eisai Co. Ltd. Financial Performance
  • Figure 29: Novartis AG Financial Performance
  • Figure 30: Pfizer Inc. Financial Performance
  • Figure 31: Merz Pharma Financial Performance
Global Anti-Infective Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Cell and Gene Therapy Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs And Biologics Logistics Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Pharmaceutical Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Microbiome Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global G-CSF (Granulocyte Colony Stimulating Factors) Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Global Therapeutic Proteins Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Read More
Neurophysiology Devices And Equipment Global Market Report 2021 - By Technology (Electromyography (EMG), Electroencephalography (EEG), Electrocorticography (ECoG), Evoked potential (EP)), By End Users (Hospitals, Ambulatory Surgical Centers), By Modality (Standalone, Portable), COVID-19 Growth And Change
View Report
Neurostimulation Devices Global Market Report 2021 - By Product (Implantable Devices, External Devices), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary And Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), By End User (Hospitals, Rehabilitation Centers, Medical Clinic), By Implantable Devices (Cochlear Implants, Deep Brain Stimulation, Spinal Cord Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electric Stimulation), By External Devices (Transcranial Magnetic Stimulation (TMS), Transcutaneous Electrical Nerve Stimulation (TENS)), COVID-19 Impact And Recovery
View Report
Interventional Neurology Devices And Equipment Global Market Report 2021 - By Type (Aneurysm Coiling & Embolization Devices, Cerebrospinal Fluid Management Devices, Neurothrombectomy Devices, Support Devices), By End-User (Hospitals, Neurology Clinics, Ambulatory Care Centers), Aneurysm Coiling & Embolization Devices By Type (Embolic Coils, Flow Diversion Devices, Liquid Embolic Devices), Angioplasty Devices By Type (Carotid Artery Stents, Embolic Protection Systems), Support Devices By Type (Micro Guide Wires, Micro Catheters), Neurothrombectomy Devices By Type (CLOT Retrieval Devices, Suction And Aspiration Devices, Snares), COVID-19 Impact And Recovery
View Report
Neurosurgery Devices And Equipment Global Market Report 2021 - By Device Type (Neuroendoscope, Stereotactic Systems, Aneurysm Clips, Neurostimulation Devices, Cerebrospinal Fluid Management Devices, Neurosurgical Evacuation Device, Neurosurgical Navigation Systems, Neurosurgery Surgical Power Tools), By Surgery Type (Intracranial Surgery, Endonasal Neurosurgery, Spinal Surgery), By End User (Hospitals, Ambulatory Surgical Centers), COVID-19 Impact And Recovery
View Report
Brain And Neuroimaging Devices Global Market Report 2021 - By Imaging Type (Functional Magnetic Resonance Imaging (fMRI), Computed Tomography (CT), Positron Emission Tomography (PET), Electroencephalography (EEG), Magneto Encephalography (MEG)), By End-User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Application (Parkinson’s Disease, Traumatic Brain Injury, Epilepsy, Dementia, Sleep Disorders), COVID-19 Growth And Change
View Report
Radiopharmaceuticals Global Market Report 2021 - By Type (Diagnostic, Therapeutic), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinnology, Neurology, Nephrology), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Cancer Research Institutes), COVID 19 Growth And Change
View Report
Neurology Devices Global Market Report 2021 - By Type (Cerebrospinal Fluid Management (CSF) Devices And Equipment, Interventional Neurology Devices And Equipment, Neurosurgery Devices And Equipment, Neurostimulation Devices), By End User (Hospitals And Clinics, Diagnostic Laboratories), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), COVID-19 Impact And Recovery
View Report
Medical Devices Market - By Type Of Device (In-Vitro Diagnostics, Dental Equipment, Ophthalmic Devices, Diagnostic Equipment, Hospital Supplies, Cardiovascular Devices, Surgical Equipment, Patient Monitoring Devices, Orthopedic Devices, Diabetes Care Devices, Nephrology And Urology Devices, ENT Devices, Anesthesia And Respiratory Devices, Neurology Devices, Wound Care Devices), By Type Of Expenditure (Public, Private), By End-User (Hospitals And Clinics, Homecare, Diagnostics Centers) And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)